NYSE:CBT - Cabot Stock Price, Forecast & News

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot declared a quarterly dividend on Friday, January 10th. Investors of record on Friday, February 28th will be given a dividend of $0.35 per share on Friday, March 13th. This represents a $1.40 annualized dividend and a yield of 3.39%. The ex-dividend date of this dividend is Thursday, February 27th. View Cabot's Dividend History.

Cabot announced that its Board of Directors has authorized a share buyback plan on Monday, July 16th 2018, which allows the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 10.3% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's management believes its stock is undervalued.

Cabot Corp (NYSE:CBT) announced its quarterly earnings results on Monday, November, 4th. The specialty chemicals company reported $1.05 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.11 by $0.06. The specialty chemicals company earned $827 million during the quarter, compared to the consensus estimate of $849.44 million. Cabot had a return on equity of 19.06% and a net margin of 4.70%. The firm's quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.00 earnings per share. View Cabot's Earnings History.

Cabot is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Cabot.

Cabot will be holding an earnings conference call on Monday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Cabot updated its FY20 earnings guidance on Monday, November, 4th. The company provided EPS guidance of $3.60-4.10 for the period, compared to the Thomson Reuters consensus estimate of $4.30.

5 analysts have issued 1 year price objectives for Cabot's shares. Their forecasts range from $41.00 to $45.00. On average, they expect Cabot's share price to reach $44.20 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price. View Analyst Price Targets for Cabot.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cabot.

Press coverage about CBT stock has trended somewhat negative on Tuesday, according to InfoTrie. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cabot earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave press coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Cabot.

Cabot saw a decrease in short interest in January. As of January 15th, there was short interest totalling 799,600 shares, a decrease of 11.6% from the December 31st total of 904,300 shares. Based on an average daily trading volume, of 271,100 shares, the short-interest ratio is presently 2.9 days. Approximately 1.4% of the shares of the stock are short sold. View Cabot's Current Options Chain.

Some companies that are related to Cabot include LyondellBasell Industries (LYB), Westlake Chemical (WLK), CHURCHILL CAP C/SH (CCC), Kronos Worldwide (KRO), Tredegar (TG), Koppers (KOP), Hawkins (HWKN) and Trecora Resources (TREC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Energy Transfer LP Unit (ET), Broadcom (AVGO), AT&T (T), Verizon Communications (VZ), Intel (INTC), Ford Motor (F), Pfizer (PFE), Cisco Systems (CSCO), Gilead Sciences (GILD) and NVIDIA (NVDA).

Cabot's stock is owned by a number of of retail and institutional investors. Top institutional investors include Strs Ohio (0.58%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.56%), Cabot Wellington LLC (0.36%), Wedge Capital Management L L P NC (0.33%), California Public Employees Retirement System (0.23%) and New York State Teachers Retirement System (0.18%). Company insiders that own Cabot stock include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.

CBT stock was sold by a variety of institutional investors in the last quarter, including Cabot Wellington LLC, Nisa Investment Advisors LLC, Arizona State Retirement System, Wedge Capital Management L L P NC, State of Alaska Department of Revenue, Biltmore Wealth Management LLC and Dupont Capital Management Corp. View Insider Buying and Selling for Cabot.

CBT stock was bought by a variety of institutional investors in the last quarter, including Strs Ohio, California Public Employees Retirement System, New York State Teachers Retirement System, Campbell & CO Investment Adviser LLC, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA and Zeke Capital Advisors LLC. View Insider Buying and Selling for Cabot.

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CBT stock can currently be purchased for approximately $41.30.

Cabot has a market capitalization of $2.35 billion and generates $3.34 billion in revenue each year. The specialty chemicals company earns $157 million in net income (profit) each year or $3.91 on an earnings per share basis. Cabot employs 4,500 workers across the globe.View Additional Information About Cabot.

The official website for Cabot is http://www.cabot-corp.com/.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]